Clinical efficacy and safety analysis of different treatment options for Cervical pregnancy
AbstractObjective To compare the efficacy and safety of different treatment options for cervical pregnancy (CP).Materials and methods A total of 74 patients diagnosed with CP at Hunan Provincial Maternal and Child Health Care Hospital between January 2016 and September 2022 were retrospectively anal...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | International Journal of Hyperthermia |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/02656736.2023.2255757 |
| _version_ | 1797374222977204224 |
|---|---|
| author | Qiaoling Zhu Yi Tang Qi Tian Hui Cheng Jing Yang Li Xiong Wei Li Lingzhi Zou Wei Cheng Xiaomei Luo |
| author_facet | Qiaoling Zhu Yi Tang Qi Tian Hui Cheng Jing Yang Li Xiong Wei Li Lingzhi Zou Wei Cheng Xiaomei Luo |
| author_sort | Qiaoling Zhu |
| collection | DOAJ |
| description | AbstractObjective To compare the efficacy and safety of different treatment options for cervical pregnancy (CP).Materials and methods A total of 74 patients diagnosed with CP at Hunan Provincial Maternal and Child Health Care Hospital between January 2016 and September 2022 were retrospectively analyzed. Among them, 31 were treated with uterine artery embolization (UAE) followed by hysteroscopic curettage, 34 were treated with hysteroscopic curettage alone, and nine were treated with high-intensity focused ultrasound (HIFU) followed by hysteroscopic curettage. Medical records and pregnancy outcomes were analyzed.Results There were no significant differences in age, gravidity, parity, abortion, or preoperative hemoglobin levels among the patients in the three groups; however, significant differences in gestational age, gestational sac diameter, preoperative β-hCG, and presence of cardiac pulsation were observed (p < 0.05). After treatment, there was no conversion to laparotomy, and the uterus was preserved in all patients. Significant differences in blood loss during curettage, hospitalization costs, hospital days, menstrual recovery interval, β-hCG decline rates, retained products of conception, and intrauterine adhesions rate among the three groups were observed (p < 0.05). There were no significant differences in the placement of the uterine Foley balloon, effective curettage rate, pre-and postoperative hemoglobin decline, live birth rate, or proportion of subsequent pregnancies among the three groups.Conclusion Our results showed that hysteroscopic curettage, HIFU, and UAE followed by hysteroscopic curettage are safe and effective for treating patients with CP. Compared with the UAE, HIFU has the advantages of lower hospitalization costs, shorter hospital stays, and shorter menstrual recovery intervals. |
| first_indexed | 2024-03-08T19:02:48Z |
| format | Article |
| id | doaj.art-6b1a37fc6b404c4e8871ba5a3bc83b8d |
| institution | Directory Open Access Journal |
| issn | 0265-6736 1464-5157 |
| language | English |
| last_indexed | 2024-03-08T19:02:48Z |
| publishDate | 2023-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | International Journal of Hyperthermia |
| spelling | doaj.art-6b1a37fc6b404c4e8871ba5a3bc83b8d2023-12-28T04:15:43ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572023-12-0140110.1080/02656736.2023.2255757Clinical efficacy and safety analysis of different treatment options for Cervical pregnancyQiaoling Zhu0Yi Tang1Qi Tian2Hui Cheng3Jing Yang4Li Xiong5Wei Li6Lingzhi Zou7Wei Cheng8Xiaomei Luo9Department of Obstetrics and Gynecology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, P.R. ChinaDepartment of Obstetrics and Gynecology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, P.R. ChinaDepartment of Obstetrics and Gynecology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, P.R. ChinaDepartment of Obstetrics and Gynecology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, P.R. ChinaDepartment of Obstetrics and Gynecology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, P.R. ChinaDepartment of Obstetrics and Gynecology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, P.R. ChinaDepartment of Obstetrics and Gynecology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, P.R. ChinaDepartment of Obstetrics and Gynecology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, P.R. ChinaDepartment of Obstetrics and Gynecology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, P.R. ChinaDepartment of Obstetrics and Gynecology, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, P.R. ChinaAbstractObjective To compare the efficacy and safety of different treatment options for cervical pregnancy (CP).Materials and methods A total of 74 patients diagnosed with CP at Hunan Provincial Maternal and Child Health Care Hospital between January 2016 and September 2022 were retrospectively analyzed. Among them, 31 were treated with uterine artery embolization (UAE) followed by hysteroscopic curettage, 34 were treated with hysteroscopic curettage alone, and nine were treated with high-intensity focused ultrasound (HIFU) followed by hysteroscopic curettage. Medical records and pregnancy outcomes were analyzed.Results There were no significant differences in age, gravidity, parity, abortion, or preoperative hemoglobin levels among the patients in the three groups; however, significant differences in gestational age, gestational sac diameter, preoperative β-hCG, and presence of cardiac pulsation were observed (p < 0.05). After treatment, there was no conversion to laparotomy, and the uterus was preserved in all patients. Significant differences in blood loss during curettage, hospitalization costs, hospital days, menstrual recovery interval, β-hCG decline rates, retained products of conception, and intrauterine adhesions rate among the three groups were observed (p < 0.05). There were no significant differences in the placement of the uterine Foley balloon, effective curettage rate, pre-and postoperative hemoglobin decline, live birth rate, or proportion of subsequent pregnancies among the three groups.Conclusion Our results showed that hysteroscopic curettage, HIFU, and UAE followed by hysteroscopic curettage are safe and effective for treating patients with CP. Compared with the UAE, HIFU has the advantages of lower hospitalization costs, shorter hospital stays, and shorter menstrual recovery intervals.https://www.tandfonline.com/doi/10.1080/02656736.2023.2255757Cervical pregnancyhigh-intensity focused ultrasounduterine artery embolizationhysteroscopycurettage |
| spellingShingle | Qiaoling Zhu Yi Tang Qi Tian Hui Cheng Jing Yang Li Xiong Wei Li Lingzhi Zou Wei Cheng Xiaomei Luo Clinical efficacy and safety analysis of different treatment options for Cervical pregnancy International Journal of Hyperthermia Cervical pregnancy high-intensity focused ultrasound uterine artery embolization hysteroscopy curettage |
| title | Clinical efficacy and safety analysis of different treatment options for Cervical pregnancy |
| title_full | Clinical efficacy and safety analysis of different treatment options for Cervical pregnancy |
| title_fullStr | Clinical efficacy and safety analysis of different treatment options for Cervical pregnancy |
| title_full_unstemmed | Clinical efficacy and safety analysis of different treatment options for Cervical pregnancy |
| title_short | Clinical efficacy and safety analysis of different treatment options for Cervical pregnancy |
| title_sort | clinical efficacy and safety analysis of different treatment options for cervical pregnancy |
| topic | Cervical pregnancy high-intensity focused ultrasound uterine artery embolization hysteroscopy curettage |
| url | https://www.tandfonline.com/doi/10.1080/02656736.2023.2255757 |
| work_keys_str_mv | AT qiaolingzhu clinicalefficacyandsafetyanalysisofdifferenttreatmentoptionsforcervicalpregnancy AT yitang clinicalefficacyandsafetyanalysisofdifferenttreatmentoptionsforcervicalpregnancy AT qitian clinicalefficacyandsafetyanalysisofdifferenttreatmentoptionsforcervicalpregnancy AT huicheng clinicalefficacyandsafetyanalysisofdifferenttreatmentoptionsforcervicalpregnancy AT jingyang clinicalefficacyandsafetyanalysisofdifferenttreatmentoptionsforcervicalpregnancy AT lixiong clinicalefficacyandsafetyanalysisofdifferenttreatmentoptionsforcervicalpregnancy AT weili clinicalefficacyandsafetyanalysisofdifferenttreatmentoptionsforcervicalpregnancy AT lingzhizou clinicalefficacyandsafetyanalysisofdifferenttreatmentoptionsforcervicalpregnancy AT weicheng clinicalefficacyandsafetyanalysisofdifferenttreatmentoptionsforcervicalpregnancy AT xiaomeiluo clinicalefficacyandsafetyanalysisofdifferenttreatmentoptionsforcervicalpregnancy |